Aprea Therapeutics, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001558370-25-011152
- Form type
- 10-Q
- CIK
- 0001781983
- Primary document
- https://www.sec.gov/Archives/edgar/data/1781983/000155837025011152/apre-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aprea Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-7.5M | - | - |
| Net Income | $-7.2M | - | - |
| Eps Basic | -1.19 | - | - |
| Eps Diluted | -1.19 | - | - |
| Cash And Equivalents | $16.5M | - | - |
| Total Assets | $17.3M | - | - |
| Shareholders Equity | $13.4M | - | - |
| Operating Cash Flow | $-6.8M | - | - |
| Capital Expenditures | $15,478 | - | - |